Franklin Biotechnology Discovery Fund
Registrant
Franklin Strategic Series
Class tickers
FBDIX
FBTDX
FRBRX
FTDZX
Net Assets
$1,154,246,884
Holdings
93
Latest Report
Jul 31, 2026
Net Assets Over Time
Holdings · 93
Export CSV
Portfolio coverage: 93 of
126 reported positions.
Showing 1–50
of 93 holdings by value
· page 1 of 2
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Amgen, Inc. | AMGN | 131,554 | $50,669,339 | 4.39% | Long | EC | |
| Gilead Sciences, Inc. | GILD | 341,817 | $44,507,992 | 3.86% | Long | EC | |
| Regeneron Pharmaceuticals, Inc. | REGN | 57,013 | $43,479,824 | 3.77% | Long | EC | |
| Argenx SE | ARGX | 48,962 | $41,804,735 | 3.62% | Long | EC | |
| Vertex Pharmaceuticals, Inc. | VRTX | 85,620 | $40,849,302 | 3.54% | Long | EC | |
| Revolution Medicines, Inc. | RVMD | 185,428 | $34,773,313 | 3.01% | Long | EC | |
| Guardant Health, Inc. | GH | 196,520 | $31,834,275 | 2.76% | Long | EC | |
| Dianthus Therapeutics, Inc. | DNTH | 250,308 | $26,762,931 | 2.32% | Long | EC | |
| Insmed, Inc. | INSM | 233,052 | $22,978,927 | 1.99% | Long | EC | |
| Mirum Pharmaceuticals, Inc. | MIRM | 215,190 | $22,799,381 | 1.98% | Long | EC | |
| Praxis Precision Medicines, Inc. | PRAX | 71,799 | $22,101,886 | 1.91% | Long | EC | |
| Spyre Therapeutics, Inc. | SYRE | 220,000 | $21,632,600 | 1.87% | Long | EC | |
| Oruka Therapeutics, Inc. | ORKA | 222,393 | $21,463,148 | 1.86% | Long | EC | |
| Neurocrine Biosciences, Inc. | NBIX | 125,643 | $20,957,252 | 1.82% | Long | EC | |
| Bridgebio Pharma, Inc. | BBIO | 241,119 | $19,311,221 | 1.67% | Long | EC | |
| PTC Therapeutics, Inc. | PTCT | 279,737 | $19,024,913 | 1.65% | Long | EC | |
| Amylyx Pharmaceuticals, Inc. | AMLX | 752,824 | $15,289,855 | 1.32% | Long | EC | |
| Eli Lilly & Co. | LLY | 13,131 | $15,085,418 | 1.31% | Long | EC | |
| Cytokinetics, Inc. | CYTK | 186,018 | $14,347,568 | 1.24% | Long | EC | |
| Tango Therapeutics, Inc. | TNGX | 521,761 | $14,181,464 | 1.23% | Long | EC | |
| EyePoint, Inc. | EYPT | 1,123,495 | $13,762,814 | 1.19% | Long | EC | |
| Abivax SA | ABVX | 109,022 | $13,619,028 | 1.18% | Long | EC | |
| Mineralys Therapeutics, Inc. | MLYS | 533,511 | $13,615,201 | 1.18% | Long | EC | |
| Arcutis Biotherapeutics, Inc. | ARQT | 505,651 | $13,581,786 | 1.18% | Long | EC | |
|
Indivior Pharmaceuticals, Inc.
|
45579U109 | 332,496 | $13,303,165 | 1.15% | Long | EC | |
| Thermo Fisher Scientific, Inc. | TMO | 22,999 | $13,208,326 | 1.14% | Long | EC | |
| Dyne Therapeutics, Inc. | DYN | 519,232 | $13,074,262 | 1.13% | Long | EC | |
| Bicara Therapeutics, Inc. | BCAX | 474,899 | $12,869,763 | 1.11% | Long | EC | |
| CG oncology, Inc. | CGON | 174,532 | $12,424,933 | 1.08% | Long | EC | |
| Benitec Biopharma, Inc. | BNTC | 995,152 | $11,653,230 | 1.01% | Long | EC | |
| Solid Biosciences, Inc. | SLDB | 1,409,093 | $11,357,290 | 0.98% | Long | EC | |
| Syndax Pharmaceuticals, Inc. | SNDX | 582,815 | $11,102,626 | 0.96% | Long | EC | |
| Ionis Pharmaceuticals, Inc. | IONS | 209,423 | $10,841,829 | 0.94% | Long | EC | |
| BeOne Medicines Ltd. | ONC | 33,421 | $10,561,370 | 0.92% | Long | EC | |
| Alnylam Pharmaceuticals, Inc. | ALNY | 51,286 | $10,540,299 | 0.91% | Long | EC | |
| Jade Biosciences, Inc. | JBIO | 479,949 | $9,478,993 | 0.82% | Long | EC | |
| Vaxcyte, Inc. | PCVX | 145,674 | $7,878,050 | 0.68% | Long | EC | |
| Xenon Pharmaceuticals, Inc. | XENE | 123,767 | $7,756,478 | 0.67% | Long | EC | |
| Relay Therapeutics, Inc. | RLAY | 404,940 | $7,625,020 | 0.66% | Long | EC | |
| ORIC Pharmaceuticals, Inc. | ORIC | 659,005 | $7,295,185 | 0.63% | Long | EC | |
| Neurogene, Inc. | NGNE | 218,783 | $7,195,773 | 0.62% | Long | EC | |
| Oruka Therapeutics, Inc. | ORKA | 73,869 | $7,129,097 | 0.62% | Long | EC | |
| Achieve Life Sciences, Inc. | ACHV | 1,095,791 | $7,034,978 | 0.61% | Long | EC | |
| BioNTech SE | BNTX | 73,400 | $6,648,572 | 0.58% | Long | EC | |
| Olema Pharmaceuticals, Inc. | OLMA | 568,915 | $6,514,077 | 0.56% | Long | EC | |
| MBX Biosciences, Inc. | MBX | 85,528 | $5,638,861 | 0.49% | Long | EC | |
| Artiva Biotherapeutics, Inc. | ARTV | 542,371 | $5,477,947 | 0.47% | Long | EC | |
| Aura Biosciences, Inc. | AURA | 765,617 | $5,366,975 | 0.46% | Long | EC | |
| Contineum Therapeutics, Inc. | CTNM | 330,090 | $5,113,094 | 0.44% | Long | EC | |
| Sionna Therapeutics, Inc. | SION | 107,956 | $5,087,966 | 0.44% | Long | EC |
Showing the top 50 of 93 holdings. Create a free account to see every holding and download the CSV.